First Republic Investment Management, Inc. Matinas Bio Pharma Holdings, Inc. Transaction History

First Republic Investment Management, Inc.

  • $34.7 Billion
  • Q3 2023

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
SELL
$0.63 - $0.96 $19,983 - $30,451
-31,720 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$0.67 - $1.51 $21,252 - $47,897
31,720 New
31,720 $41,000
Q3 2019

Nov 08, 2019
SELL
$0.59 - $0.9 $17,700 - $27,000
-30,000 Closed
0 $0
Q1 2018

May 10, 2018
BUY
$0.76 - $1.32 $22,800 - $39,600
30,000 New
30,000 $23,000
Q4 2017

Feb 09, 2018
SELL
$1.1 - $1.54 $33,000 - $46,200
-30,000 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$1.19 - $1.43 $35,700 - $42,900
30,000
30,000 $40,000

Others Institutions Holding MTNB

# of Institutions
6
Shares Held
3.52M
Call Options Held
0
Put Options Held
0
View Full List

About Matinas BioPharma Holdings, Inc.

MTNB Quotes by TradingView
  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email